Yahoo! Finance Canada report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Why CLBT Stock slipped -0.16% Today — RQD Quant Desk Flash
Cellebrite DI Ltd. (CLBT) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is CLBT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Cellebrite DI Ltd. (NASDAQ: CLBT) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $12.13 (-0.16% 1D, market cap $3.05B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 15/20. Across 715 tracked Technology issuers, CLBT ranks #91 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does CLBT compare to VIA and SPSC in the Technology sector?
▼
Within the Technology sector (Computer Software: Prepackaged Software), CLBT carries a Roarable C+ (69/100 RQD), trailing P/E of 39.4x, gross margin of 84.2%, and ROIC of 14.6%. By comparison, VIA (Via Transportation Inc. (Class A)) holds a D grade (50/100 RQD, P/E N/A, ROIC -23.6%, cap $2.97B) and SPSC (SPS Commerce Inc.) posts a C+ grade (69/100 RQD, P/E 33.1x, ROIC 11.4%, cap $2.94B). Among the 5-stock peer group, ALRM leads on earnings multiple (24.8x) while TDC leads on capital efficiency (85.0% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for CLBT?
▼
Per CLBT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001854587), Cellebrite DI Ltd. generated $475.7M in revenue (+18.6% YoY), $78.3M in net income, and $160.3M in free cash flow against $938.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (84.2% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 4.95 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
SEC XBRL FY 2025 (10-K): 33.7% FCF Margin ($160.3M FCF) & 84.2% Gross Margin
Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)
⚔️ Adversarial Opposing Case: Why the CLBT Bull Thesis Could Fail
Even with a 69/100 (C+) score, CLBT faces multiple-compression risk if 39.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Priced at 39x earnings—high expectations leave less room for a lukewarm quarter.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($11.54) or 200D SMA ($13.35) invalidates the momentum regime and cuts Target Base ($12.73) toward Bear Floor ($9.93).
Why CLBT Stock slipped -0.16% Today — RQD Quant Desk Flash
Cellebrite DI Ltd. (CLBT) slipped -0.16% to $12.13, trading at 25% of its 52-week range ($9.58 – $19.98). Solid 84.2% gross margin (15% return on capital), mixed timing at 39x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 25% of its 52-week range ($9.58 – $19.98) with RSI-14 at 57.3 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.4% around $12.13 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 84.2% gross margin and $160.3M annual free cash flow.
GuruFocus report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
A record $6b crypto theft at Binance has pushed cybersecurity from background concern to front-page risk, and investors are suddenly rethinking where the real leverage in digital finance sits. Volatility in crypto platfo
Regulators just gave crypto platforms the green light to keep paying interest style rewards on certain digital assets, which keeps fresh oxygen flowing into this corner of the market. That decision keeps the spotlight on
Scheduled RQD Strong Buys & Whale Accumulation Briefing (CLBT Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
CLBT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +18.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CLBT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CLBT. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CLBT)
1. Head-to-Head Technology Peer Comparison (CLBT vs. VIA, SPSC, ALRM, TDC)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 715 tracked Technology securities in the Roarable RQD universe, Cellebrite DI Ltd. (CLBT) ranks #91 by composite RQD confidence (69/100, grade C+) and #252 by equity capitalization ($3.05B). Within this direct 5-issuer industry benchmark cohort, ALRM leads on earnings valuation at 24.8x trailing P/E, while TDC leads on capital efficiency and profitability with 85.0% ROIC and 59.4% gross margin. ALRM currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with CLBT at 69/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CLBT
ACTIVE
Cellebrite DI Ltd. | C+ | 69/100 | 39.4x | 84.2% | 14.6% | -0.16% | $3.05B | Benchmark Subject |
| VIA Via Transportation Inc. (Class A) | D | 50/100 | — | 39.6% | -23.6% | +0.03% | $2.97B | /via-vs-clbt → |
| SPSC SPS Commerce Inc. | C+ | 69/100 | 33.1x | 69.2% | 11.4% | +2.52% | $2.94B | /spsc-vs-clbt → |
| ALRM Alarm.com Holdings Inc. | B | 73/100 | 24.8x | 66.1% | 64.6% | +1.80% | $3.18B | /alrm-vs-clbt → |
| TDC Teradata Corporation | C+ | 66/100 | 24.8x | 59.4% | 85.0% | -1.87% | $3.19B | /tdc-vs-clbt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001854587 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cellebrite DI Ltd. (CLBT) reported GAAP revenue of $475.7M (+18.6% vs. FY2024 revenue of $401.2M , and +46.3% cumulative change since FY2023) , GAAP net income of $78.3M, operating cash flow of $173.5M, and free cash flow of $160.3M (+29.7% YoY). On the balance sheet, CLBT closed FY2025 with $938.9M in total assets against $0 in total debt (Altman Z-Score: 4.95, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $475.7M | $78.3M | $173.5M | $160.3M | $938.9M | — |
| FY2024 (FY) | 2024-12-31 | $401.2M | -$283.0M | $132.2M | $123.6M | $690.6M | — |
| FY2023 (FY) | 2023-12-31 | $325.1M | -$81.1M | $102.1M | $102.1M | — | — |
3. CLBT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CLBT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Cellebrite DI Ltd. (NASDAQ: CLBT) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $12.13 (-0.16% 1D, market cap $3.05B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 15/20. Across 715 tracked Technology issuers, CLBT ranks #91 in composite RQD confidence.
How does CLBT compare to VIA and SPSC in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), CLBT carries a Roarable C+ (69/100 RQD), trailing P/E of 39.4x, gross margin of 84.2%, and ROIC of 14.6%. By comparison, VIA (Via Transportation Inc. (Class A)) holds a D grade (50/100 RQD, P/E N/A, ROIC -23.6%, cap $2.97B) and SPSC (SPS Commerce Inc.) posts a C+ grade (69/100 RQD, P/E 33.1x, ROIC 11.4%, cap $2.94B). Among the 5-stock peer group, ALRM leads on earnings multiple (24.8x) while TDC leads on capital efficiency (85.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CLBT?
Per CLBT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001854587), Cellebrite DI Ltd. generated $475.7M in revenue (+18.6% YoY), $78.3M in net income, and $160.3M in free cash flow against $938.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (84.2% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CLBT trading relative to its 50-day, 200-day, and 52-week technical levels?
CLBT last traded at $12.13 (-0.16% on volume of 1,587,913 shares), positioning the stock +5.11% above its 50-day simple moving average ($11.54) and -9.14% below its 200-day simple moving average ($13.35). Across its 52-week range of $9.58 to $19.98, CLBT sits at the 24.5% percentile with a 14-day RSI of 57.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.4% ($11.23 to $13.03).
CLBT — Cellebrite DI Ltd.: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Cellebrite DI Ltd. (CLBT) earns a live Roarable RQD composite score of 69/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $12.13 (-0.16% 1D, market capitalization $3.05B).
- Fundamental Cash Engine (17/20): Anchored by return on invested capital (ROIC) of 14.6%, gross margin of 84.2%, operating margin of 14.0%, and free cash flow yield of 5.19%.
- Whale 13F & Options Flow (9/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (10/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of 4.95, Piotroski F-Score of 8/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Cellebrite DI Ltd. (CLBT) is a NASDAQ-listed issuer in the Technology sector, Computer Software: Prepackaged Software industry. Per the market data, the company reports a gross margin of 84.2%, an operating margin of 14%, and a net margin of 16.5%. —: product lines, customer segments, and the specific mechanics of how the company generates revenue.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Cellebrite DI Ltd. (CLBT) reported $475.7M in annual revenue (up from $401.2M in FY2024, +18.6% YoY) and $78.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($325.1M revenue, -$81.1M net income) through FY2025, CLBT scaled operating cash flow to $173.5M and free cash flow to $160.3M, backed by $938.9M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (C+ • RQD 69/100): Strong cash generator (84.2% gross margin)—profits are backed by real money, not accounting tricks. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 17/20 and Institutional Whale Flow at 9/20, sustained execution supports upside toward the upper end of the $9.58 – $19.98 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 39.4x trailing P/E and 38.1x EV/EBITDA against 14.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Operating in Computer Software: Prepackaged Software (Technology), CLBT carries a macro regime beta of 1.00 and gross margin of 84.2%.
- Key Question #1: Can CLBT sustain or expand its 14.0% operating margin and 14.6% ROIC against Computer Software: Prepackaged Software peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $475.7M and free cash flow of $160.3M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is CLBT's 33.1x forward P/E multiple to Technology capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
CLBT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Cellebrite DI Ltd. (CLBT) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo! Finance Canada report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Cellebrite DI Ltd. (CLBT) market action, institutional positioning, and fundamental catalysts.
CLBT Bull vs. Bear Conversation Board — What's Your Call at $12.13?
Per the Roarable RQD rating, ROIC of 14.6% and a Piotroski F of 8/9 point to a cash-generative, financially sound business.
Per the Roarable RQD rating, ROIC of 14.6% and a Piotroski F of 8/9 point to a cash-generative, financially sound business.. When you look under the hood at CLBT, Fundamental Cash Engine is 17/20 with 84.2% gross margins and 14.6% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (9/20) has been quietly accumulating below $19.98. My 12M target is $13.97.
@DeepValue_CFA Agree on the RQD 69/100 quality, though with 1.0 beta I'm scaling in with half-size at $12.15 and keeping dry powder in case we test $11.30.
Trailing P/E of 39.4 and EV/EBITDA of 38.1 are elevated, leaving the stock exposed if cash-flow growth slows.
Trailing P/E of 39.4 and EV/EBITDA of 38.1 are elevated, leaving the stock exposed if cash-flow growth slows.. Look at the math on CLBT: paying 39.4x trailing P/E for 14.6% ROIC and 14.0% operating margins leaves zero margin of safety if Computer Software: Prepackaged Software demand softens. I'd wait for a retest of $10.69 before getting long.